The body's own clotting process ends with a single reaction: fibrinogen converting into fibrin, the fibrous protein that gives a blood clot its structure. Fibrin sealant technology is built directly around this final step, delivering concentrated fibrinogen and thrombin to a surgical site so that a stable fibrin clot can form rapidly and locally, independent of how well the rest of the patient's clotting cascade is functioning at that moment.
This piece covers what a fibrin sealant is composed of, how the two-component chemistry produces its effect, and the general surgical contexts where this category of sealant is used.
What Components Make Up a Fibrin Sealant?
Fibrin sealants are generally supplied as two-component systems that are combined at the time of use, typically through a dual-syringe or similar delivery device that mixes the components as they are applied. One component contains concentrated fibrinogen, along with other clotting-related proteins depending on the specific formulation. The other component contains thrombin, often combined with calcium, which is needed as a cofactor in the clotting reaction. Keeping these two components separate until the point of application is essential, since combining fibrinogen and thrombin is what triggers the reaction that forms fibrin.
How Does Mixing These Components Create a Seal?
When the fibrinogen and thrombin components meet, thrombin acts enzymatically on fibrinogen, cleaving it into fibrin monomers that spontaneously polymerize into a fibrin network — essentially the same final structural step that occurs in natural blood clotting, but concentrated and delivered directly to the surgical site. This fibrin network forms a mechanical seal over the application area and additionally serves as a scaffold that can support the wound-healing process as the surrounding tissue heals. Because this reaction is driven by the sealant's own components rather than depending heavily on the patient's own clotting factor levels, fibrin sealants are commonly discussed as an option in situations where a patient's underlying coagulation status may be a relevant consideration for the surgical team.
Where Are Fibrin Sealants Typically Used in Surgery?
Fibrin sealants are used across a range of surgical contexts, generally where a broad, oozing surface needs to be sealed or where achieving watertight or airtight closure is clinically relevant. Reported uses commonly include hemostasis on parenchymal organ surfaces, support for tissue apposition in select reconstructive contexts, and, in some formulations, use in sealing air leaks after certain thoracic procedures. The specific approved indications vary considerably by manufacturer and by regulatory region, so the applicable product's Instructions for Use (IFU) should always be consulted rather than assuming uniform indications across the fibrin sealant category as a whole.
How Do Fibrin Sealants Differ From Cyanoacrylate Tissue Adhesives?
Both categories are sometimes grouped together informally as "surgical glues," but their underlying chemistry is quite different. Fibrin sealants work by recreating a biological clotting reaction using proteins related to the body's own hemostatic system, while cyanoacrylate tissue adhesives work through a synthetic polymerization reaction triggered by tissue moisture. Fibrin-based products are generally understood to be more biologically integrated with the healing process, while cyanoacrylate adhesives are known for very rapid polymerization, generally within seconds. Neither mechanism is inherently preferable across all situations; selection depends on the specific surgical need, the tissue involved, and the surgeon's clinical judgment.
What Should Be Kept in Mind About Fibrin Sealant Use?
As with any hemostatic or sealant product, fibrin sealants are intended to be used as directed in the manufacturer's IFU, applied to appropriately prepared tissue, and are not a substitute for definitive surgical control of active bleeding through direct techniques such as ligation or suturing where those are indicated. Handling instructions, including component storage, mixing, and application device use, vary meaningfully between manufacturers and should never be assumed to be interchangeable across brands.
What are the two components in a fibrin sealant?
Fibrin sealants are generally composed of a fibrinogen-containing component and a thrombin-containing component (often combined with calcium), which are mixed together at the point of application. Combining the two triggers the reaction that converts fibrinogen into a stable fibrin clot at the surgical site.
Is a fibrin sealant the same thing as a blood clot?
It produces a similar end structure to a natural blood clot because it uses concentrated versions of the same proteins involved in the body's own clotting cascade. However, it is a manufactured medical product applied intentionally during surgery, not a spontaneous physiological clot.
Can fibrin sealants be used in patients with clotting disorders?
This is a clinical decision that depends heavily on the individual patient's specific condition and overall surgical context, and it should be made by the treating physician or surgical team based on the patient's full medical history. General articles like this one cannot substitute for that individualized clinical assessment.
Fibrin sealant technology is one of several sealant and hemostat categories referenced within INVAMED's broader hemostatic tissue sealant solutions portfolio, alongside absorbable hemostats, flowable matrices, and tissue adhesives.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.